Skip to Content

FDA clears ResMed's pediatric nasal mask

FDA clears ResMed's pediatric nasal mask

SAN DIEGO - ResMed announced last month plans to launch the Mirage Kidsta nasal mask and the VPAP III ST-A--the first-ever pediatric system cleared by the FDA for treatment of obstructive sleep apnea and respiratory insufficiency in the hospital and home. The FDA cleared the use for children 7 years and older, or weighing more than 40 pounds. The VPAP III ST-A is currently available and the Mirage Kidsta is expected to ship in late summer. The prevalence and seriousness of sleep apnea among children has gained recognition in recent years. A 2003 study in the journal Pediatrics found that children whose parents reported frequent or loud snoring or other sleep-disordered breathing (SDB) were more likely to be sleepy during the day or have problem behaviors like hyperactivity.

Comments

To comment on this post, please log in to your account or set up an account now.